HBM Healthcare Investments AG (SIX: HBMN)

http://www.hbmhealthcare.com

HBM Healthcare Investments invests in the healthcare sector. The company holds and manages an international portfolio of promising companies in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided in their strategic direction. This is what makes HBM Healthcare Investments an interesting alternative to investments in big pharma and biotechnology companies. HBM Healthcare Investments, with funds under management of more than EUR 1 bn, has an international shareholder base and is listed on SIX Swiss Exchange (HBMN). *

	Start	2012-12-19 existent
	Group	HBM (Group)
	Predecessor	HBM BioVentures AG
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Wicki, Andreas (HBM Healthcare Investments 201402 CEO)

	Street	1 Bundesplatz
	City	6300 Zug
	Tel	+41-41-768-1108
		Address record changed: 2018-07-24

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	1,000,000,000 (funds, managed (2018) 2018-11-26)

		* Document for ï¿½About Sectionï¿½: Adrenomed AG. (11/26/18). "Press Release: Adrenomed Closes EUR 24 M Financing Led by Wellington and HBM". Hennigsdorf, Munich & Zug.

		Record changed: 2020-10-10